Unleash iMM’s research excellence in immunity and infection through twinning to infect Lisbon and Portugal with its increase in competitiveness and innovation
The Instituto de Medicina Molecular (iMM Lisboa) is a leading Portuguese private non-profit research institute that offers a vibrant scientific environment, aiming to nurture innovative ideas in basic, clinical and translational Biomedical Research. iMM was created in 2002 with a vision to achieve a world-class research portfolio focusing on innovative conceptual niches from the molecule to the bedside, in an institute where science meets medicine. iMM's mission is to improve human health through the study of disease mechanisms and the development of novel diagnostic tests and therapeutic approaches. iMM’s overall strategy has been defined by promotion of excellence, leveraged by high-quality human resources, increasing expenditure in infrastructures and knowledge transfer to the society.
We are already counting on the contribution of the abovelisted Research groups. The entire scientific community of Immunity and Infection research field at iMM Lisboa is invited to participate in TwinnToInfect.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 692022